Valid for Submission
T86.812 is a billable diagnosis code used to specify a medical diagnosis of lung transplant infection. The code T86.812 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The appropriate 7th character is to be added to each code from block Complications of transplanted organs and tissue (T86). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code T86.812:
Use Additional CodeUse Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
- code to specify infection
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code T86.812 are found in the index:
Diagnostic Related Groups - MS-DRG Mapping
Convert T86.812 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code T86.812 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Information for Patients
A lung transplant removes a person's diseased lung and replaces it with a healthy one. The healthy lung comes from a donor who has died. Some people get one lung during a transplant. Other people get two.
Lung transplants are used for people who are likely to die from lung disease within 1 to 2 years. Their conditions are so severe that other treatments, such as medicines or breathing devices, no longer work. Lung transplants most often are used to treat people who have severe
- Cystic fibrosis
- Idiopathic pulmonary fibrosis
- Alpha-1 antitrypsin deficiency
- Pulmonary hypertension
Complications of lung transplantation include rejection of the transplanted lung and infection.
NIH: National Heart, Lung, and Blood Institute
- Lung transplant (Medical Encyclopedia)
[Learn More in MedlinePlus]